# FDA Inspection 1102566 - Biomat USA, Inc. - July 31, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e01185be-5e56-44e5-952f-5762ec988a85
Source feed: FDA_Inspections

> FDA Inspection 1102566 for Biomat USA, Inc. on July 31, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102566
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-07-31
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 987064 - 2016-08-03](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/669c71a2-26b0-436a-918b-d4bd4a6770d7)
- [FDA Inspection 836607 - 2013-06-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/29260b18-755d-429f-a6f7-239b4b610cf8)
- [FDA Inspection 623330 - 2009-10-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f0045299-38fd-4849-8519-0e4c735fc610)

Company: https://www.keypedia.com/companies/biomat-usa-inc/b4a63c3d-75d3-460f-8439-3f8efa323a83

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d